Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Sponsor: Blueprint Medicines Corporation
Summary
This is a Phase 4, non-interventional, observational study to collect detailed data on the clinical characteristics, clinical outcomes and medical management of ISM in real-world settings. The study will describe the demographic and clinical characteristics of ISM participants, including anaphylaxis and bone manifestations in ISM. Quality of life and disease control will be assessed through participant questionnaires. The study will also evaluate real world ISM treatment management, including use of avapritinib.
Official title: An Observational Study in Patients With Indolent Systemic Mastocytosis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2026-02-01
Completion Date
2032-12-01
Last Updated
2025-12-04
Healthy Volunteers
No